News stories about Avinger (NASDAQ:AVGR) have trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Avinger earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave news coverage about the medical device company an impact score of 46.0272266336974 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Avinger (NASDAQ AVGR) opened at 0.452 on Wednesday. The firm’s market capitalization is $10.81 million. Avinger has a 52-week low of $0.35 and a 52-week high of $5.15. The stock’s 50 day moving average price is $0.47 and its 200 day moving average price is $1.21.

AVGR has been the subject of several analyst reports. Canaccord Genuity cut Avinger from a “buy” rating to a “hold” rating in a research report on Tuesday, April 11th. Oppenheimer Holdings, Inc. reaffirmed a “market perform” rating on shares of Avinger in a research report on Wednesday, April 12th. CIBC cut Avinger from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 12th. Zacks Investment Research raised Avinger from a “hold” rating to a “buy” rating and set a $0.50 price objective for the company in a research report on Friday, April 14th. Finally, Cowen and Company reaffirmed a “buy” rating on shares of Avinger in a research report on Friday, April 14th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $4.13.

COPYRIGHT VIOLATION NOTICE: “Avinger (NASDAQ:AVGR) Earning Somewhat Favorable Media Coverage, Study Shows” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at

About Avinger

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

Insider Buying and Selling by Quarter for Avinger (NASDAQ:AVGR)

Receive News & Ratings for Avinger Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger Inc. and related companies with's FREE daily email newsletter.